Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Keryx Biopharm Inc (KERX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2002	12-2001	12-2000	12-1999
Assets
Current Assets
Cash & Cash Equivalents	13,350	23,345	22,708	N/A
Marketable Securities	10,874	14,308	15,493	N/A
Receivables	473	465	800	N/A
Income taxes - deferred	170	N/A	N/A	N/A
Other current assets	0	203	0	0
TOTAL	$24,867	$38,321	$39,001	$N/A

Non-Current Assets
PPE Net	3,031	3,338	312	N/A
Investments And Advances	117	291	10,240	0
Other Non-Current Assets	1,088	1,117	711	0
TOTAL	$4,236	$4,746	$11,263	$N/A

Total Assets	$29,103	$43,067	$50,264	$N/A

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	920	2,099	919	0
Accrued Expenses	1,420	710	174	N/A
TOTAL	$2,517	$3,086	$1,093	$N/A

Non-Current Liabilities
Long Term Debt	188	766	304	N/A
TOTAL	$256	$766	$304	$N/A

Total Liabilities	$2,773	$3,852	$1,397	$N/A

Shareholders' Equity
Shares Outstanding, K	20,077	19,895	N/A	N/A
Common Shares	20	19	19	N/A
Retained earnings	-45,502	-33,719	-23,913	N/A
Other shareholders' equity	-255	-1,110	-3,805	0
TOTAL	$26,330	$39,215	$48,867	$N/A

Total Liabilities And Equity	$29,103	$43,067	$50,264	$0